Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 29/05/19981 min de lecture
Oral Dosage Form New Animal Drugs; Milbemycin Oxime Tablet
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for expanding the indications to include separate dosage and labeling for use of milbemycin oxime in cats.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →